A Review of the First Transdermal Treatment for Alzheimer--™s Disease -- The Rivastigmine Patch | Psychiatry
Links shared publicly online about this topic.
- 665total visits
A Review of the First Transdermal Treatment for Alzheimer--™s Disease -- The Rivastigmine Patch | Psychiatry
View full resource at touchpsychiatry.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Exelon, Psychiatry, Psychology, disease
Most Recently Shared on December 10, 2010 at 12:54 pm By:
A Review of the First Transdermal Treatment for Alzheimer’s Disease – The Rivastigmine Patch http://bit.ly/e5bBox
A Review of the First Transdermal Treatment for Alzheimer--™s Disease -- The Rivastigmine Patch | Psychiatry
touchpsychiatry.com — “A Review of the First Transdermal Treatment for Alzheimer--™s Disease” View full resource at touchpsychiatry.com
Most Recently Shared on February 19, 2011 at 2:02 pm By:
Touch Psychiatry Medical Journal and Psychology
A Review of the First Transdermal Treatment for Alzheimer’s Disease – The Rivastigmine Patch http://bit.ly/fe0Ui2
FDA Accepts Aricept, Patch (Donepezil Transdermal System) NDA For Review - QualityPoint Technologies
qualitypointtech.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept,, a leading medication for the treatment of Alzheimer's disease. The company developed the weekly Aricept(r) patch based on a license agreement executed between Teikoku Pharma USA, Inc. and Eisai Co., Ltd. (Eisai) in February 2009. The acceptance of the NDA indic” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:13 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review: Teikoku Pharma USA, Inc., an internat... http://bit.ly/cojyJC
FDA accepts to review Aricept NDA for Alzheimer's disease
news-medical.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept, a leading medication for the treatment of Alzheimer's disease.” View full resource at news-medical.net
Most Recently Shared on September 18, 2010 at 4:29 am By:
FDA accepts to review Aricept NDA for Alzheimer's disease: Teikoku Pharma USA, Inc., an international specialty ph... http://bit.ly/9cGJqS
Treatment for Couple's Pain Makes Laughter Conceivable - Advertising Age - Garfield's Ad Review
adage.com — “This is about a funny, knowing and smart DTC drug campaign now being tested in Baltimore. But first, just a quick reminder that pharma marketing is a cesspool.” View full resource at adage.com
Most Recently Shared on March 16, 2010 at 12:40 am By:
Fabio Gratton Health Social Media and Health Executive
RT @roskadigital: GREAT unbranded campaign from EMD Serono ... nice writeup in Ad Age: http://bit.ly/aWAsLa
Advertisement
